Glucose-Sensing ChREBP Protein in the Pathogenesis of Diabetic Retinopathy
2024

Role of Glucose-Sensing ChREBP in Diabetic Retinopathy

publication Evidence: moderate

Author Information

Author(s): Christopher R. Starr, Assylbek Zhylkibayev, Oleg Gorbatyuk, Alli M. Nuotio-Antar, James Mobley, Maria B. Grant, Marina Gorbatyuk

Primary Institution: University of Alabama at Birmingham, School of Medicine, Department of Ophthalmology

Hypothesis

We aimed to investigate the potential role of ChREBP in the pathogenesis of diabetic retinopathy (DR).

Conclusion

ChREBP overexpression causes significant metabolic reprogramming triggering retinal functional loss in mice.

Supporting Evidence

  • ChREBP and MondoA are expressed across the retina, with distinct distribution patterns.
  • Elevated expression of both proteins was observed in diabetic retinopathy.
  • ChREBP overexpression in rod photoreceptors leads to diminished scotopic ERG amplitudes.
  • Proteomic analysis indicated a decline in pathways associated with phototransduction and amino acid metabolism.

Takeaway

This study found that a protein called ChREBP, which senses glucose, can cause problems in the eyes of mice with diabetes, leading to vision loss.

Methodology

The study used diabetic human and mouse retinal cryosections analyzed by immunohistochemistry, qRT-PCR for gene expression, and proteomic analysis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1101/2024.12.04.626828

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication